Rocket One RKTO
NASDAQ RKTO
$0.67 -0.02 (-3.29%)
As of: Sep 9, 2026 · 3:33 PM EDT

Rocket One (RKTO) Research & Development (2018 - 2026)

Rocket One's (RKTO) quarterly Research & Development came in at $2.0 million in Q2 2026, up 88.07% year-over-year from $1.0 million in Q2 2025, and up 28.73% quarter-over-quarter from $1.5 million in Q1 2026.

Analysis

Rocket One (RKTO) Research & Development (2018 - 2026) Analysis & Trends

Rocket One has disclosed Research & Development across 9 years of filings, most recently posting $2.0 million for Q2 2026.

  • In Q2 2026, Research & Development rose 88.07% year-over-year to $2.0 million; the TTM figure through Jun 2026 stood at $6.4 million (up 27.64% YoY), while the FY2025 annual figure was $5.9 million, up 83.02% from the prior year.
  • Research & Development came in at $2.0 million for Q2 2026 at Rocket One, up from $1.5 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $2.0 million in Q1 2025 to a low of -$3.4 million in Q4 2022.
  • Average Research & Development over 5 years is $912308.1, with a median of $1.0 million recorded in 2024.
  • Year-over-year, Research & Development slumped 44.55% in 2022 and soared 242.63% in 2025.
  • Over 5 years, Research & Development stood at -$3.4 million in 2022, then surged by 123.71% to $796763.0 in 2023, then jumped by 30.4% to $1.0 million in 2024, then advanced by 26.53% to $1.3 million in 2025, then soared by 48.75% to $2.0 million in 2026.
  • Per Business Quant data, the three most recent Research & Development figures were $2.0 million in Q2 2026, $1.5 million in Q1 2026, and $1.3 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Amgen 212.04 Bn 198.05 Bn 7.24 Bn 1.87 Bn
2 Gilead Sciences 181.35 Bn 178.17 Bn 6.22 Bn 1.76 Bn
3 Vertex Pharmaceuticals 132.22 Bn 124.37 Bn 2.84 Bn 993.80 Mn
4 Regeneron Pharmaceuticals 82.94 Bn 74.94 Bn 3.93 Bn 1.63 Bn
5 Argenx Se 61.53 Bn 56.34 Bn 1.37 Bn -486.00 Mn
6 Moderna 54.25 Bn 49.11 Bn 52.00 Mn 651.00 Mn
7 Alnylam Pharmaceuticals 34.41 Bn 31.10 Bn 992.69 Mn 413.13 Mn
8 Biogen 31.19 Bn 29.91 Bn 1.96 Bn 529.60 Mn
9 Roivant Sciences 30.10 Bn 30.10 Bn 1.16 Mn 202.02 Mn
10 Rocket One 13.87 Mn 5.98 Mn - 1.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.96 Mn
Mar 31, 2026 1.52 Mn
Dec 31, 2025 1.31 Mn
Sep 30, 2025 1.63 Mn
Jun 30, 2025 1.04 Mn
Mar 31, 2025 1.96 Mn
Dec 31, 2024 1.04 Mn
Sep 30, 2024 994,474.00
Jun 30, 2024 644,025.00
Mar 31, 2024 571,642.00
Dec 31, 2023 796,763.00
Sep 30, 2023 1.34 Mn
Jun 30, 2023 663,999.00
Mar 31, 2023 942,886.00
Dec 31, 2022 -3.36 Mn
Sep 30, 2022 1.45 Mn
Jun 30, 2022 971,182.00
Mar 31, 2022 948,379.00
Dec 31, 2021 -4.44 Mn
Sep 30, 2021 2.12 Mn